Home

NSV Partners III GP LLC

CIK 1889601 · last filed 2024-06-26

NSV Partners III GP LLC is a corporate insider who has filed 11 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for VTYX, was dated Jun 26, 2024. Across all open-market trades the lifetime net is −$36.8M, making them a net seller over the disclosed history. The firm reports its address in Greenwich, CT. 22 SEC filings were submitted jointly with NSV Partners III LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

11

Lifetime Open-Market Net

-$36.77M

Filer Profile

Reported Address
500 WEST PUTNAM AVE
SUITE 400
GREENWICH, CT 06830
Phone
(212) 688-5100
State of Incorporation
DE
Related Filers
NSV Partners III LP — 22 joint filings, latest 2024-06-26
NSV Investments I, L.P. — 3 joint filings, latest 2022-12-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ventyx Biosciences, Inc. (VTYX) Delisted 10%+ Owner 15,659,835 $13.99 $219.08M -$36.77M 11 2024-06-26

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-26 Ventyx Biosciences, Inc. (VTYX) Delisted Other (J) −1,282,654 $0 EDGAR
2024-04-16 Ventyx Biosciences, Inc. (VTYX) Delisted Other (J) −1,390,678 $0 EDGAR
2023-09-20 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −113,330 -$4.29M EDGAR
2023-07-13 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −63,842 -$2.40M EDGAR
2023-07-11 Ventyx Biosciences, Inc. (VTYX) Delisted Mixed −2,260,682 -$7.05M EDGAR
2023-06-08 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −80,000 -$2.85M EDGAR
2023-04-10 Ventyx Biosciences, Inc. (VTYX) Delisted Other (J) −3,494,196 $0 EDGAR
2023-03-07 Ventyx Biosciences, Inc. (VTYX) Delisted Other (J) −1,118,734 $0 EDGAR
2022-12-19 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −600,000 -$19.97M EDGAR
2022-12-15 Ventyx Biosciences, Inc. (VTYX) Delisted Other (J) −10,023,786 $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.